Rosen Law Firm Investigates Securities Claims for Simulations Plus Shareholders
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Source: PRnewswire
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ:SLP) for possibly issuing misleading business information, allowing affected shareholders to seek compensation without any out-of-pocket costs.
- Performance Miss: Simulations Plus reported $20.4 million in sales for Q3 2025, a 10% year-over-year increase, but fell short of the $20.9 million consensus estimate, resulting in a 25.75% stock drop on July 15, 2025, indicating market concerns about the company's outlook.
- Class Action Preparation: The firm is preparing a class action lawsuit against Simulations Plus to recover investor losses, emphasizing the importance of selecting qualified legal counsel with a proven track record in securities litigation to protect investor rights effectively.
- Firm's Strength: Rosen Law Firm secured over $438 million for investors in 2019 and achieved the largest securities class action settlement against a Chinese company in 2017, showcasing its significant expertise and success in the securities litigation field.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like SLP with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on SLP
Wall Street analysts forecast SLP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SLP is 19.00 USD with a low forecast of 19.00 USD and a high forecast of 19.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 18.630
Low
19.00
Averages
19.00
High
19.00
Current: 18.630
Low
19.00
Averages
19.00
High
19.00
About SLP
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Rosen Law Firm Investigates Securities Claims for Simulations Plus Shareholders
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ:SLP) for possibly issuing misleading business information, allowing affected shareholders to seek compensation without any out-of-pocket costs.
- Performance Miss: Simulations Plus reported $20.4 million in sales for Q3 2025, a 10% year-over-year increase, but fell short of the $20.9 million consensus estimate, resulting in a 25.75% stock drop on July 15, 2025, indicating market concerns about the company's outlook.
- Class Action Preparation: The firm is preparing a class action lawsuit against Simulations Plus to recover investor losses, emphasizing the importance of selecting qualified legal counsel with a proven track record in securities litigation to protect investor rights effectively.
- Firm's Strength: Rosen Law Firm secured over $438 million for investors in 2019 and achieved the largest securities class action settlement against a Chinese company in 2017, showcasing its significant expertise and success in the securities litigation field.
Continue Reading
Rosen Law Firm Investigates Securities Claims Against Simulations Plus
- Securities Claim Investigation: The Rosen Law Firm is investigating potential securities claims against Simulations Plus (NASDAQ: SLP) for allegedly issuing misleading business information, indicating significant legal risks for the company.
- Underperformance Report: Simulations Plus reported third-quarter 2025 sales of $20.4 million, a 10% year-over-year increase, but fell short of the $20.9 million consensus estimate, highlighting the company's weakening performance and declining market confidence.
- Stock Price Plunge: Following the disappointing earnings report on July 15, 2025, Simulations Plus's stock plummeted by 25.75%, reflecting investor concerns about the company's future outlook and the severity of market reactions.
- Class Action Preparation: The Rosen Law Firm is preparing a class action lawsuit, allowing investors to participate in claims without upfront costs, emphasizing the importance of legal support for investor rights and the necessity of addressing potential losses.
Continue Reading